We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Hutchmed (China) Limited 28 January 2025 Overseas Regulatory Announcement - Disposal Transaction HUTCHMED (China) Limited ("HUTCHMED") notes the below text, which is from an announcement...
Ltd - Hong Kong-based biopharmaceutical firm - Says its lung cancer treatment Orpathys has received full approval in C ...
Hutchmed (China) Limited 14 January 2025 Press Release HUTCHMED Announces NMPA Full Approval for ORPATHYS® (savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon...
Hutchmed (China) Ltd on Thursday said it has agreed to divest a 45% stake in Shanghai Hutchison Pharmaceuticals Ltd t ...
Hutchmed (China) Limited 02 January 2025 Press Release HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer...
Hutchmed (China) Limited 02 January 2025 Overseas Regulatory Announcement - Disposal Transaction HUTCHMED (China) Limited ("HUTCHMED") notes the below text, which is from an...
Hutchmed (China) Limited 02 January 2025 HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture - HUTCHMED continues to deliver on its strategy outlined in November 2022 to...
Hutchmed (China) Limited 31 December 2024 Appointment of Cavendish as Joint Corporate Broker in London Hong Kong, Shanghai & Florham Park, NJ - Tuesday, December 31, 2024: HUTCHMED...
Hutchmed (China) Limited 30 December 2024 Blocklisting Six Monthly Return Hong Kong, Shanghai & Florham Park, NJ - Monday, December 30, 2024: HUTCHMED (China) Limited ("HUTCHMED" or...
Ltd - Hong Kong-based biopharmaceutical firm - Is to receive a USD10 million milestone payment from partner Takeda Pha ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.5 | 1.15207373272 | 217 | 228 | 214 | 28129 | 220.03530851 | DE |
4 | -22.5 | -9.29752066116 | 242 | 259 | 214 | 41319 | 233.89978944 | DE |
12 | -60.5 | -21.6071428571 | 280 | 300 | 214 | 50814 | 252.78332415 | DE |
26 | -70.5 | -24.3103448276 | 290 | 336 | 214 | 100453 | 286.68042903 | DE |
52 | 19.5 | 9.75 | 200 | 353 | 190.4 | 84027 | 285.63708566 | DE |
156 | -170 | -43.6456996149 | 389.5 | 423.5 | 130 | 95767 | 246.80688749 | DE |
260 | -150.5 | -40.6756756757 | 370 | 656 | 130 | 100175 | 347.58186352 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions